US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 0.715
  • -0.009-1.23%
Close Dec 20 16:00 ET
  • 0.642
  • -0.073-10.17%
Post 20:01 ET
258.36MMarket Cap-0.97P/E (TTM)

Lexicon Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-28.83%-53.62M
-27.34%-48.54M
-74.39%-55.13M
-82.21%-161.9M
-134.35%-50.55M
-114.10%-41.62M
-56.08%-38.12M
-34.98%-31.61M
-2.11%-88.85M
5.52%-21.57M
Net income from continuing operations
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
Operating gains losses
----
----
----
----
----
----
----
----
-93.88%3K
----
Depreciation and amortization
-16.56%126K
-3.47%139K
28.57%144K
29.74%554K
42.72%147K
39.81%151K
34.58%144K
2.75%112K
46.23%427K
-8.04%103K
Other non cash items
869.74%5.99M
-1,696.70%-4.36M
9.81%291K
-414.57%-2.33M
-1,110.72%-3.49M
184.79%618K
77.27%273K
960.00%265K
1,272.22%741K
4,212.50%345K
Change In working capital
23.41%9.69M
66.34%4.25M
-230.45%-11.47M
561.44%2.66M
-182.16%-4.28M
705.33%7.85M
187.26%2.56M
-21.75%-3.47M
103.93%402K
1,248.70%5.21M
-Change in receivables
-174.93%-275K
-158.63%-1.09M
-120.51%-516K
-6,914.29%-982K
-5,866.67%-692K
6,216.67%367K
-14,200.00%-423K
-917.39%-234K
-103.67%-14K
33.33%12K
-Change in inventory
68.90%-51K
58.72%-71K
---133K
---381K
---45K
---164K
---172K
--0
--0
--0
-Change in prepaid assets
-43.27%969K
76.01%-666K
-116.72%-1.88M
-817.41%-2.9M
-725.97%-964K
551.91%1.71M
-176.22%-2.78M
-417.58%-867K
-110.95%-316K
-82.89%154K
-Change in payables and accrued expense
45.12%8.87M
2.52%5.91M
-228.81%-9.11M
8,392.11%6.45M
-156.31%-2.65M
654.69%6.11M
369.52%5.77M
16.26%-2.77M
100.54%76K
750.07%4.71M
-Change in other current assets
202.33%176K
6.21%171K
-58.50%166K
-28.81%467K
-76.15%78K
-89.01%-172K
-24.41%161K
93.24%400K
-0.76%656K
61.88%327K
Cash from discontinued investing activities
Operating cash flow
-28.83%-53.62M
-27.34%-48.54M
-74.39%-55.13M
-82.21%-161.9M
-134.35%-50.55M
-114.10%-41.62M
-56.08%-38.12M
-34.98%-31.61M
-2.11%-88.85M
5.52%-21.57M
Investing cash flow
Cash flow from continuing investing activities
235.96%53.47M
83.48%-12.32M
-1,011.47%-110.22M
29.73%-49.94M
114.69%51.9M
49.06%-39.33M
-446.66%-74.61M
374.34%12.09M
-3,468.63%-71.08M
296.56%24.17M
Net PPE purchase and sale
-269.88%-307K
-79.86%-250K
--0
64.56%-470K
--0
-1,975.00%-83K
---139K
-226.32%-248K
-8.60%-1.33M
-5,317.39%-1.25M
Net investment purchase and sale
237.03%53.78M
83.79%-12.07M
-993.15%-110.22M
29.07%-49.47M
104.16%51.9M
49.16%-39.24M
-445.64%-74.47M
384.88%12.34M
-2,194.03%-69.75M
315.43%25.42M
Cash from discontinued investing activities
Investing cash flow
235.96%53.47M
83.48%-12.32M
-1,011.47%-110.22M
29.73%-49.94M
114.69%51.9M
49.06%-39.33M
-446.66%-74.61M
374.34%12.09M
-3,468.63%-71.08M
296.56%24.17M
Financing cash flow
Cash flow from continuing financing activities
-336.19%-916K
-100.01%-14K
29,151.33%239.38M
32.17%187.96M
-100.00%-1K
-100.22%-210K
189M
-103.54%-824K
526.22%142.21M
320.00%24.91M
Net issuance payments of debt
--0
----
----
2.24%49.96M
-100.00%-1K
100.40%1K
----
----
517.68%48.87M
313.41%24.97M
Net common stock issuance
--0
-100.00%1K
-99.27%-1.64M
47.84%138M
--0
-100.22%-211K
--139.03M
4.63%-824K
171.27%93.34M
-116.62%-63K
Net preferred stock issuance
---10K
---15K
--241.43M
----
----
--0
--0
--0
----
----
Net other financing activities
---906K
--0
---400K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-336.19%-916K
-100.01%-14K
29,151.33%239.38M
32.17%187.96M
-100.00%-1K
-100.22%-210K
--189M
-103.54%-824K
526.22%142.21M
320.00%24.91M
Net cash flow
Beginning cash position
-65.17%35.62M
271.12%96.49M
-51.53%22.47M
-27.66%46.35M
12.12%21.12M
376.79%102.27M
-56.32%26M
-27.66%46.35M
-49.26%64.07M
-79.55%18.83M
Current changes in cash
98.69%-1.07M
-179.82%-60.88M
463.89%74.03M
-34.76%-23.88M
-95.10%1.35M
-3,002.26%-81.16M
300.34%76.27M
-347.61%-20.34M
71.51%-17.72M
198.07%27.51M
End cash Position
63.62%34.55M
-65.17%35.62M
271.12%96.49M
-51.53%22.47M
-51.53%22.47M
12.12%21.12M
376.79%102.27M
-56.32%26M
-27.66%46.35M
-27.66%46.35M
Free cash flow
-29.31%-53.93M
-27.54%-48.79M
-73.03%-55.13M
-80.05%-162.37M
-121.56%-50.55M
-114.48%-41.7M
-56.65%-38.26M
-35.60%-31.86M
-2.20%-90.18M
0.16%-22.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -28.83%-53.62M-27.34%-48.54M-74.39%-55.13M-82.21%-161.9M-134.35%-50.55M-114.10%-41.62M-56.08%-38.12M-34.98%-31.61M-2.11%-88.85M5.52%-21.57M
Net income from continuing operations -28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M
Operating gains losses ---------------------------------93.88%3K----
Depreciation and amortization -16.56%126K-3.47%139K28.57%144K29.74%554K42.72%147K39.81%151K34.58%144K2.75%112K46.23%427K-8.04%103K
Other non cash items 869.74%5.99M-1,696.70%-4.36M9.81%291K-414.57%-2.33M-1,110.72%-3.49M184.79%618K77.27%273K960.00%265K1,272.22%741K4,212.50%345K
Change In working capital 23.41%9.69M66.34%4.25M-230.45%-11.47M561.44%2.66M-182.16%-4.28M705.33%7.85M187.26%2.56M-21.75%-3.47M103.93%402K1,248.70%5.21M
-Change in receivables -174.93%-275K-158.63%-1.09M-120.51%-516K-6,914.29%-982K-5,866.67%-692K6,216.67%367K-14,200.00%-423K-917.39%-234K-103.67%-14K33.33%12K
-Change in inventory 68.90%-51K58.72%-71K---133K---381K---45K---164K---172K--0--0--0
-Change in prepaid assets -43.27%969K76.01%-666K-116.72%-1.88M-817.41%-2.9M-725.97%-964K551.91%1.71M-176.22%-2.78M-417.58%-867K-110.95%-316K-82.89%154K
-Change in payables and accrued expense 45.12%8.87M2.52%5.91M-228.81%-9.11M8,392.11%6.45M-156.31%-2.65M654.69%6.11M369.52%5.77M16.26%-2.77M100.54%76K750.07%4.71M
-Change in other current assets 202.33%176K6.21%171K-58.50%166K-28.81%467K-76.15%78K-89.01%-172K-24.41%161K93.24%400K-0.76%656K61.88%327K
Cash from discontinued investing activities
Operating cash flow -28.83%-53.62M-27.34%-48.54M-74.39%-55.13M-82.21%-161.9M-134.35%-50.55M-114.10%-41.62M-56.08%-38.12M-34.98%-31.61M-2.11%-88.85M5.52%-21.57M
Investing cash flow
Cash flow from continuing investing activities 235.96%53.47M83.48%-12.32M-1,011.47%-110.22M29.73%-49.94M114.69%51.9M49.06%-39.33M-446.66%-74.61M374.34%12.09M-3,468.63%-71.08M296.56%24.17M
Net PPE purchase and sale -269.88%-307K-79.86%-250K--064.56%-470K--0-1,975.00%-83K---139K-226.32%-248K-8.60%-1.33M-5,317.39%-1.25M
Net investment purchase and sale 237.03%53.78M83.79%-12.07M-993.15%-110.22M29.07%-49.47M104.16%51.9M49.16%-39.24M-445.64%-74.47M384.88%12.34M-2,194.03%-69.75M315.43%25.42M
Cash from discontinued investing activities
Investing cash flow 235.96%53.47M83.48%-12.32M-1,011.47%-110.22M29.73%-49.94M114.69%51.9M49.06%-39.33M-446.66%-74.61M374.34%12.09M-3,468.63%-71.08M296.56%24.17M
Financing cash flow
Cash flow from continuing financing activities -336.19%-916K-100.01%-14K29,151.33%239.38M32.17%187.96M-100.00%-1K-100.22%-210K189M-103.54%-824K526.22%142.21M320.00%24.91M
Net issuance payments of debt --0--------2.24%49.96M-100.00%-1K100.40%1K--------517.68%48.87M313.41%24.97M
Net common stock issuance --0-100.00%1K-99.27%-1.64M47.84%138M--0-100.22%-211K--139.03M4.63%-824K171.27%93.34M-116.62%-63K
Net preferred stock issuance ---10K---15K--241.43M----------0--0--0--------
Net other financing activities ---906K--0---400K----------------------------
Cash from discontinued financing activities
Financing cash flow -336.19%-916K-100.01%-14K29,151.33%239.38M32.17%187.96M-100.00%-1K-100.22%-210K--189M-103.54%-824K526.22%142.21M320.00%24.91M
Net cash flow
Beginning cash position -65.17%35.62M271.12%96.49M-51.53%22.47M-27.66%46.35M12.12%21.12M376.79%102.27M-56.32%26M-27.66%46.35M-49.26%64.07M-79.55%18.83M
Current changes in cash 98.69%-1.07M-179.82%-60.88M463.89%74.03M-34.76%-23.88M-95.10%1.35M-3,002.26%-81.16M300.34%76.27M-347.61%-20.34M71.51%-17.72M198.07%27.51M
End cash Position 63.62%34.55M-65.17%35.62M271.12%96.49M-51.53%22.47M-51.53%22.47M12.12%21.12M376.79%102.27M-56.32%26M-27.66%46.35M-27.66%46.35M
Free cash flow -29.31%-53.93M-27.54%-48.79M-73.03%-55.13M-80.05%-162.37M-121.56%-50.55M-114.48%-41.7M-56.65%-38.26M-35.60%-31.86M-2.20%-90.18M0.16%-22.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.